J Clin Oncol 26 (24): 3950-7, 2008.[PUBMED Abstract] Sledge GW, Neuberg D, Bernardo P, et al.: Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).
J Clin Oncol 21 (4): 588-92, 2003.[PUBMED Abstract] Seidman AD: Sequential single-agent chemotherapy for metastatic breast cancer: therapeutic nihilism or realism?
J Clin Oncol 21 (4): 577-9, 2003.[PUBMED Abstract] Overmoyer B: Combination chemotherapy for metastatic breast cancer: reaching for the cure.
J Clin Oncol 21 (4): 580-2, 2003.[PUBMED Abstract] Honig SF: Hormonal therapy and chemotherapy.